Status:
COMPLETED
Hypomagnesemia Associated With Proton-Pump Inhibitor Use
Lead Sponsor:
Changi General Hospital
Conditions:
Proton Pump Inhibitor Adverse Reaction
Hypomagnesemia
Eligibility:
All Genders
14-100 years
Brief Summary
Use of proton pump inhibitors has been associated with hypomagnesemia. However, various case-control or prospective studies have found conflicting results with regards to proton pump inhibitors use an...
Eligibility Criteria
Inclusion
- Patients admitted with hypomagnesemia (cases)
- Patients prescribed with proton pump inhibitors (controls)
Exclusion
- Patients prescribed with less than three months duration of proton pump inhibitors (controls)
Key Trial Info
Start Date :
January 31 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
211672 Patients enrolled
Trial Details
Trial ID
NCT04426994
Start Date
January 31 2017
End Date
September 30 2019
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changi General Hospital
Singapore, Singapore, 529889